Virchow Medical Strengthens Scientific Advisory Board with New Appointments
Board welcomes Mayo Clinic Laboratories CEO Dr. William Morice and Clinical Lab 2.0 Founder Khosrow Shotorbani; Second Annual In-Person Advisory Meeting in San Diego Drives Directions for Product Development
Virchow Medical, Inc., a company advancing biopsy specimen stewardship to expand access to precision oncology, today announced three milestones that strengthen its scientific leadership and accelerate its innovation roadmap. The first milestone is William Morice II, MD, PhD, President and Chief Executive Officer of Mayo Clinic Laboratories, has joined the Virchow Medical Scientific Advisory Board (SAB). In addition, Khosrow Shotorbani, Chief Executive Officer of Project Santa Fe Foundation and Founder of Clinical Lab 2.0, has transitioned from the Company’s Market Outreach Advisory Board to the Scientific Advisory Board, joining Dr. Morice and other SAB members.
Virchow Medical also recently convened its annual in-person SAB meeting at the Company’s headquarters in San Diego. The four-hour working session brought together leading experts in pathology, oncology, and laboratory medicine and resulted in several new, high-impact initiatives for the company’s product development pipeline.
